HEALTH MATTERS 9 update
he Board of the HSE announced in may the appointment of Mr Cathal Magee as the next Chief Executive of the HSE to succeed Professor Brendan drumm whose term of office ends in mid August. Cathal Magee is a former Managing
CEO Designate T
Director of Eircom’s b1.3 billion portfolio of retail businesses that serve the consumer, business, corporate, and Government markets. He was also interim Chief Executive of the group for six months to july 2009. Previously he held other senior management posts in Eircom as Managing Director, Eircom Ireland, managing director, Business Transformation and as HR Director. As well as his extensive commercial and business operating experience, he has been a central leadership figure in the extensive transformation and restructuring of the company. Early last year he concluded a major breakthrough agreement with the trade unions to enable the next phase of restructuring of the business.
Prior to joining Eircom, Mr Magee worked for the national Australia Bank group in the UK and Ireland. He has also worked in a Business Transformation and HR director capacity with Bord na mona from 1988 to1992 involving business and operational restructuring. His early career was in the Health Service.
He holds a first class honours degree in Management from the IMI and a MSc in organisational Behaviour from Trinity College, Dublin. He is currently a Non Executive Director of VHI Healthcare and the EBS Building Society.
The Chairman of the HSE Board, mr liam downey stated, “The Board is very pleased to have attracted a highly experienced professional for the position of CEO for the HSE. Cathal Magee has an extensive record of implementing change and performance improvement in a number of organisations and different environments. He has worked in both the public and private sectors and
demonstrated a high level of achievement and successful engagement with a wide range of interests and stakeholders.” Mr. Magee will take up his new appointment on September 1st next.
Dr Susan O’Reilly appointed as Director of NCCP D
r Susan O’Reilly has been appointed as the new Director of the National Cancer
Control Programme (nCCP) to succeed Professor Tom Keane whose contract with the Programme ended earlier this year. Welcoming Dr O’Reilly’s appointment, HSE CEo Professor Brendan drumm said: “We are delighted that Dr O’Reilly will be joining the HSE and leading the next stage
in the development of our national cancer programme. Dr O’Reilly will bring great experience, expertise and leadership to the continued transformation and development of cancer services in Ireland.” Dr O’Reilly is currently the Vice President of Cancer Care at the British Columbia Cancer Agency (BCCA), based in vancouver, Canada. She was appointed to this role in 2005 and is responsible for strategy, financial planning and delivery of both medical and operational components of all clinical programmes for cancer patients in the five Cancer Agency centres. She is the clinical Professor of Medical Oncology in the Faculty of medicine at the university of British Columbia and for 13 years, until 2008, was Professor and Head of the Division of Medical Oncology at the University of British Columbia, Head of medical oncology at the BC Cancer Agency and vancouver General Hospital and Provincial Systemic Programme leader at the British Columbia Cancer Agency.
Dr O’Reilly grew up in South Wales and graduated with an honours degree (BSc) in Electrical Engineering from the University of Wales, Swansea. She subsequently completed her medical education at Trinity College, dublin (mB, BCh, BAo, BA (Hons). After post graduate training in Internal Medicine in both Trinity College and University College Dublin teaching hospitals, she moved to Vancouver to specialise in Medical Oncology. Her clinical interests as a medical oncologist in Vancouver have been in care and research in lymphomas, breast cancer and gynaecological cancers. She is a Fellow of the Royal College of Physicians of Ireland and of the Royal College of Physicians and Surgeons of Canada and her current interests are in provision of timely, high quality cancer control services and innovative programs in complex healthcare systems.
Dr O’Reilly will take up her new appointment in early September 2010.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124